Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | FATE | AMGN | GILD | VRTX | BIIB |
Company | Fate Therapeutics | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
Open | 4.30 | 313.39 | 65.51 | 401.50 | 215.30 |
High | 4.50 | 322.60 | 65.53 | 405.67 | 217.88 |
Low | 4.05 | 308.68 | 64.33 | 397.59 | 213.11 |
Last | 4.06 | 311.29 | 64.78 | 401.08 | 217.51 |
Change | -0.04 | +32.90 | -0.55 | +0.92 | +4.00 |
% Change | -0.98% | +11.82% | -0.84% | +0.23% | +1.87% |
Volume | 2,025,100 | 9,644,601 | 7,822,700 | 1,064,000 | 1,144,100 |
20-Day Average Volume | 2,708,785 | 2,646,885 | 7,406,455 | 1,022,600 | 1,344,250 |
Previous Close | 4.10 | 278.39 | 65.33 | 400.16 | 213.51 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | Yes | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 4.96 | 272.27 | 66.88 | 398.43 | 203.10 |
20-Day Raw Stochastic | 9.88% | 81.73% | 8.01% | 63.17% | 95.41% |
20-Day Relative Strength | 32.01% | 72.10% | 30.11% | 47.14% | 56.41% |
Weighted Alpha | -53.37 | +33.76 | -22.64 | +14.36 | -29.51 |
Today's Opinion | 16% Sell | 24% Buy | 100% Sell | 8% Buy | 56% Sell |
Previous Opinion | 8% Sell | 16% Sell | 100% Sell | 8% Buy | 56% Sell |
Last Month's Opinion | 80% Buy | 24% Sell | 100% Sell | 24% Buy | 100% Sell |
Performance | |||||
5-Days | |||||
%Chg | +6.84% since 04/26/24 | +15.30% since 04/26/24 | -0.98% since 04/26/24 | +0.91% since 04/26/24 | +4.12% since 04/26/24 |
Low | 3.79 on 04/29/24 | 268.99 on 04/29/24 | 64.33 on 05/03/24 | 391.70 on 04/30/24 | 208.54 on 04/29/24 |
High | 4.50 on 05/03/24 | 322.60 on 05/03/24 | 66.91 on 04/29/24 | 406.95 on 05/01/24 | 218.86 on 04/29/24 |
1-Month | |||||
%Chg | -42.08% since 04/03/24 | +13.44% since 04/03/24 | -8.62% since 04/03/24 | -1.89% since 04/03/24 | +5.39% since 04/03/24 |
Low | 3.74 on 04/26/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
High | 7.34 on 04/04/24 | 322.60 on 05/03/24 | 71.39 on 04/04/24 | 412.64 on 04/04/24 | 218.86 on 04/29/24 |
3-Month | |||||
%Chg | -37.73% since 02/02/24 | -3.68% since 02/02/24 | -15.83% since 02/02/24 | -5.56% since 02/02/24 | -10.75% since 02/02/24 |
Low | 3.74 on 04/26/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
High | 8.83 on 03/07/24 | 329.72 on 02/05/24 | 77.87 on 02/06/24 | 437.00 on 02/27/24 | 246.44 on 02/07/24 |
6-Month | |||||
%Chg | +69.87% since 11/03/23 | +15.35% since 11/03/23 | -20.60% since 11/03/23 | +6.61% since 11/03/23 | -12.82% since 11/03/23 |
Low | 1.91 on 11/10/23 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 341.90 on 11/16/23 | 189.44 on 04/19/24 |
High | 8.83 on 03/07/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 268.30 on 01/03/24 |
Key Statistics | |||||
Market Capitalization, $K | 462,097 | 166,968,480 | 80,656,088 | 103,662,736 | 31,668,802 |
Shares Outstanding, K | 113,817 | 536,376 | 1,245,077 | 258,459 | 145,597 |
Annual Sales | 63,530,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
Annual Net Income | -160,930,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
Last Quarter Sales | 1,680,000 | 8,196,000,000 | 6,686,000,000 | 2,517,700,000 | 2,290,500,000 |
Last Quarter Net Income | -44,120,000 | 767,000,000 | -4,170,000,000 | 968,800,000 | 393,400,000 |
60-Month Beta | 1.80 | 0.60 | 0.22 | 0.39 | -0.01 |
Per-Share Information | |||||
Most Recent Earnings | -0.45 on 02/26/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 4.20 on 02/05/24 | 3.67 on 04/24/24 |
Latest Earnings Date | 05/01/24 | 05/02/24 | 04/25/24 | 05/06/24 | 04/24/24 |
Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
Ratios | |||||
Price/Earnings ttm | 0.00 | 14.94 | 16.21 | 29.77 | 14.23 |